MedPath

Comparison of dutasteride and finasteride for the treatment of male pattern hair loss in me

Phase 3
Completed
Conditions
Health Condition 1: null- Androgenetic Alopecia
Registration Number
CTRI/2015/01/005482
Lead Sponsor
okmanya Tilak Municipal Medical College General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

AGA with Grade 3v(vertex), grade IV or grade V of Modified Hamilton Norwood

AGA with female pattern hair loss - graded as F1, F2 or F3 as per BASP classification.

Patient who are willing to give consent to participate in the study.

Exclusion Criteria

Use of minoxidil within previous 6 months

Use of drugs with androgenetic/anti-androgenetic properties within previous 6 months

History of breast cancer/ prostate cancer/ first degree relative with prostate cancer before the age of 50

Use of drugs that cause hypertrichosis (phenytoin, acetazolamide, cyclosporine, diazoxide, psoralens, minoxidil, penicillamine, streptomycin, cortisone) and hypotrichosis(anti-coagulants, retinoids, lithium, beta blockers) in the past 6 months

Uncontrolled Diabetes mellitus or hypertension

Chronic smokers or tobacco chewers

Hair Transplantation or hair weaving within 6 months

Light or laser treatment of scalp within previous 3 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath